期刊文献+

复发或转移性乳腺癌3种代表化疗方案的成本-效果分析 被引量:1

Cost-effectiveness analysis of cancer with 3 chemical therapy schemes
下载PDF
导出
摘要 目的:评价复发或转移性乳腺癌3种代表化疗方案的成本-效果。方法:对52例复发或转移性乳腺癌化疗患者分别采用3种给药方案治疗,方案A为AT方案,方案B为XT方案,方案C为GT方案,治疗2个周期评价疗效。运用药物经济学方法进行成本-效果分析。结果:3种化疗方案成本分别为32700.88元、28321.88元、45861.68元,显效率分别为63.15%、62.50%、64.71%,成本-效果比分别为517.83、453.15、708.73。不良反应为不同程度的骨髓抑制、恶心呕吐、脱发等、手足综合征、血小板变化等,经对症治疗病人均耐受。结论:方案B为最优方案。 Objective:To conduct cost-effectiveness analysis with 3 chemical therapy schemes on soaked mammary cancer after surgery.Methods:52 Soaked mammary cancer cases were treated with 3 schemes respectively, and scheme A is AT, scheme B is XT , scheme C is GT.The curative effects were observed and analyzed by cost-effectiveness method.Results:They cost 32700.88, 28321.88,45861.68 yuan respectively, and the effective rates were 63.15% ,62.50% ,64.71%.The cost-effectiveness ratios were 517.83,453.15,708.73 respectively.Conclusion:Scheme B is the best.
出处 《中国药物应用与监测》 CAS 2007年第2期25-28,共4页 Chinese Journal of Drug Application and Monitoring
关键词 复发或转移性乳腺癌 化疗方案 成本-效果分析 Soaked mammary cancer after surgery Chemical therapy schemes Cost-effectiveness analysis
  • 相关文献

参考文献4

  • 1[1]Oshaughnessy J,Miles D,Vuklja S,et al.Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer Ⅲ trial results[J].J Clin Oncol,2002,20:2812.
  • 2[2]Albain KS,Nag S,Calderillo-ruiz G,et al.Global phase Ⅲ study of gemcitabine plus paclitaxel (GT) vs.pacliaxel (T) as frontline therapy for metastatic breast cancer (MBC):First Report of Overall Survival[J].J Clin Oncol,2004,14S:510.
  • 3何志高,陈洁,张丹.药物经济学研究中成本的确定[J].中国药房,1998,9(3):100-101. 被引量:148
  • 4郭文萍.4种治疗前列腺炎方案的成本-效果分析[J].中国药房,2003,14(5):284-285. 被引量:17

二级参考文献3

共引文献160

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部